ASDAS-CRP | BASDAI | |||||
---|---|---|---|---|---|---|
Standard coefficient | Regression coefficient (95% CI) | p Value | Standard coefficient | Regression coefficient (95% CI) | p Value | |
HLA-B27 positivity | −0.11 | −0.23 (−0.40 to −0.05) | 0.01 | −0.13 | −0.53 (−0.86 to −0.21) | <0.001 |
Caucasian race | −0.16 | −0.56 (−0.83 to −0.28) | <0.001 | −0.17 | −0.91 (−1.45 to −0.38) | 0.001 |
Male gender | NS | NS | NS | −0.09 | −0.34 (−0.68 to −0.00) | 0.048 |
CRP | NI | NI | NI | 0.11 | 0.18 (0.03 to 0.33) | 0.02 |
ESR | NI | NI | NI | 0.13 | 0.31 (0.10 to 0.52) | 0.01 |
MRI spinal inflammation | 0.10 | 0.24 (0.04 to 0.44) | 0.02 | NS | NS | NS |
MRI SIJ inflammation | NS | NS | NS | −0.16 | −0.66 (−1.00 to −0.32) | <0.001 |
ASDAS, Ankylosing Spondylitis Disease Activity Score (CRP-based); BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; HLA-B27, human leucocyte antigen B27; NI, not included in multivariate analysis; NS, not significant in multivariate analysis; SIJ, sacroiliac joints.